Transcutaneous Electrical Nerve Stimulation Treatment of Renal Colic

Adiyaman University Research Hospital100 enrolled

Overview

The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.

Renal colic, an intensely painful condition, is a common presenting complaint to the emergency department. Parenteral opioids, nonsteroidal anti-inflammatory drugs and acetaminophen are commonly used to provide relief from renal colic. The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department. Study Design and Setting: A prospective, randomized, double-blind, placebo controlled, single-center, clinical trial will be conducted in emergency department of a tertiary care university hospital.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

100

Conditions

Renal Colic

Interventions

TENSDEVICE

Transcutaneous electrical nerve stimulation (TENS) treatment will be activated.

placebo groupDEVICE

Transcutaneous electrical nerve stimulation treatment will not be activated.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adult patients with renal colic admitted to emergency department. 2. Adult patients who were definitively diagnosed with acute renal colic due to urinary system stones using unenhanced computed abdominopelvic tomography Exclusion Criteria: 1. Patients below 18 years of age 2. Patients with haemodynamic instability, with fever (temperature=38°C \[100.4°F\]), with evidence of peritoneal inflammation, 3. Patients using any analgesic within the previous 48 hours of emergency department presentation 4. Patients who declined to participate

Locations (1)

Adiyaman University Research Hospital

Adıyaman, Central, Turkey (Türkiye)

Outcomes

Primary Outcomes

Reduction of the intensity of pain

Subjects will complete 100 mm visual analog scales at time zero, 15 and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Time frame: 0 minutes, 15 minutes and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Secondary Outcomes

Adverse events

30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Time frame: 30 minutes after

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.